Your browser doesn't support javascript.
loading
Sino-nasal hemangiopericytoma: a case series and systematic literature review.
Warman, Meir; Syn-Hershko, Adi; Cohen, Oded; Tzipin, Yevgeny; Lahav, Yonatan; Tessler, Idit.
Afiliação
  • Warman M; Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, POB 1, 76100, Rehovot, Israel. meirwarma@gmail.com.
  • Syn-Hershko A; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. meirwarma@gmail.com.
  • Cohen O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Tzipin Y; Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, POB 1, 76100, Rehovot, Israel.
  • Lahav Y; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Tessler I; Department of Radiology, Invasive Radiology Unit, Kaplan Medical Center, Rehovot, Israel.
Eur Arch Otorhinolaryngol ; 279(8): 3989-3996, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35103868
BACKGROUND: Hemangiopericytoma is a rare tumor of the sino-nasal tract. Its clinical behavior is controversial. Whereas some describe an indolent course, others consider it to be an aggressive lesion with a tendency toward rapid local recurrence. Here, we describe our experience in the management of sino-nasal hemangiopericytoma (SN-HPC), comparing our experience with the current literature, and evaluating signs and tools to improve diagnosis and treatment. METHODS: All cases of SN-HPC between 2010 and 2020 were extracted and reviewed from our institutional electronic medical records. SN-HPC cases from PubMed and EMBASE between 2010 and 2020 were analyzed in a systematic literature review using the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. Data regarding demographics, presentation, diagnosis, treatment, and outcome were collected. RESULTS: We identified four cases of SN-HPC in the nasal cavity in our institution and an additional 53 cases in previous reports. The mean age at the time of diagnosis was 59 years, with a 1.2:1 male to female ratio. SN-HPC mostly appears unilaterally, arising in the ethmoid sinus (42.1%). The most common presenting symptoms were epistaxis (47.3) and nasal obstruction (47.3%). Both computed tomography (CT) and magnetic resonance imaging (MRI) were required for diagnosis and for tailoring the treatment plan. Endoscopic surgical excision was used in 85.9% of the patients, and in 15.7%, an additional preoperative embolization was performed, which was associated with septal necrosis in one patient (2.6%). The recurrence rate was 7%. CONCLUSION: Although previous reports attribute an aggressive tumoral behavior to SN-HPC, our experience and the literature review support a more indolent course with low recurrence rates following complete endoscopic resection. Preoperative embolization can be useful in certain cases, but due to potential complications, it should not be routinely indicated.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasais / Hemangiopericitoma Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Eur Arch Otorhinolaryngol Assunto da revista: OTORRINOLARINGOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasais / Hemangiopericitoma Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Eur Arch Otorhinolaryngol Assunto da revista: OTORRINOLARINGOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel